Fundz

PANDA Therapeutics secures €160K from Venture Kick to advance its multi-target Alzheimer’s therapy towards clinical development.

PRIVATEAug 31, 2026

Amount Raised

€160,000

Round Type

Pre-Seed

SwitzerlandBiotechnologyHealth CareTherapeutics

Investors

Venture Kick

Description

PANDA Therapeutics has obtained €160,000 from Venture Kick to advance a new treatment for Alzheimer’s disease. The funding will primarily support company formation and business development. Its innovative treatment targets multiple protein deposits simultaneously. This approach aims to provide a broader and longer-lasting solution for Alzheimer’s progression.

Quick answer

PANDA Therapeutics raised €160,000 in a Pre-Seed round, dated August 31, 2026. Investors: Venture Kick. PANDA Therapeutics is based in Switzerland.

How much did PANDA Therapeutics raise?
PANDA Therapeutics raised €160,000 in a Pre-Seed round on August 31, 2026.
Who invested in PANDA Therapeutics?
Venture Kick is named as investors in this round.
What does PANDA Therapeutics do?
PANDA Therapeutics is a biotech startup focused on developing a first-in-class antibody-based therapy for Alzheimer’s disease.
Where is PANDA Therapeutics based and how big is it?
PANDA Therapeutics is based in Switzerland.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as PANDA Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Os Therapies raised $7.2M on October 15, 2026.
  • Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
  • Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
  • Float Bio raised $140K (Pre-Seed) on October 15, 2026.
  • seragy holding GmbH raised $13M on October 14, 2026.
  • Soufflé Therapeutics raised $135M (Series B) on October 13, 2026.

Who to call at PANDA Therapeutics, and when

A new round usually means PANDA Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day PANDA Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PANDA Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PANDA Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PANDA Therapeutics

Location

Switzerland

About

PANDA Therapeutics is a biotech startup focused on developing a first-in-class antibody-based therapy for Alzheimer’s disease. The company aims to target multiple harmful protein deposits in the brain simultaneously, improving treatment effectiveness and slowing disease progression. Founded by CEO Hui Zhang, who has extensive experience in drug discovery in Neuroscience, PANDA seeks to engage global pharmaceutical and biotechnology companies as strategic partners.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PANDA Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for PANDA Therapeutics's next move

See what Strategic adds

PANDA Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.